An integrative analytical approach designed for feasible tranexamic acid assay using o‐phthalaldehyde as a fluorogenic probe: applications to tablets, ampoules, and urine
- 6 November 2023
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 38 (12) , 1988-1995
Abstract
Antifibrinolytic tranexamic acid (TRX) suppresses plasminogen activation to plasmin in a competitive way. TRX is approved for the management of heavy menstrual periods, hereditary angioedema, hemophilia, postpartum hemorrhage, surgery, tooth extraction, and severe blood loss after acute trauma. Here, the practical use of an isoindole derivative was established for a novel, easy‐to‐use, and affordable TRX assay. In the presence of a molecule containing a sulfhydryl group (2‐mercaptoethanol) 0.02% v/v, the primary amine moiety in TRX allows its combination with o‐phthalaldehyde to produce a luminous product. Excitation (338.8 nm) and emission (433.9 nm) wavelengths were used to monitor the isoindole fluorophore yield, and each operational variable was carefully examined and adjusted. The calibration graph was constructed with fluorescence intensity versus TRX concentration, excellent linearity was observed at concentrations between 40 and 950 ng/ml, and limit of detection and limit of quantitation were 41.3 and 13.6 ng/ml, respectively. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines were used to validate the method. The developed method for TRX assay in various dosage forms and urine was successfully implemented and was shown to be an effective, simple, and quick replacement for the TRX assay in clinical trials and quality control.Keywords
Funding Information
- Shaqra University
This publication has 21 references indexed in Scilit:
- Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o‐phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samplesLuminescence, 2012
- Spectrophotometric techniques to determine tranexamic acid: Kinetic studies using ninhydrin and direct measuring using ferric chlorideJournal of Molecular Structure, 2008
- Optimization and Validation of an HPLC-UV Method for Determination of Tranexamic Acid in a Dosage Form and in Human UrineChromatographia, 2007
- Spectrophotometric and Spectrofluorimetric Methods for the Determination of Tranexamic Acid in Pharmaceutical FormulationChemical and Pharmaceutical Bulletin, 2007
- Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cellsThrombosis and Haemostasis, 2007
- An ionizable chromophoric reagent for the analysis of primary amine-containing drugs by capillary electrophoresisElectrophoresis, 2005
- Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamineJournal of Pharmaceutical and Biomedical Analysis, 2002
- HPLC determination of tranexamic acid in pharmaceutical preparations and bloodChromatographia, 2001
- Spectrophotometric determination of tranexamic acid with chloranilTalanta, 1984
- Pharmacokinetics and bioavailability of tranexamic acidEuropean Journal of Clinical Pharmacology, 1981